STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
STRATEC Biomedical AG
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Financière de l'Echiquier, Paris, France has notified us pursuant to sec.
21 para. 1 WpHG on 17 April 2014, that on 16 April 2014 the share of voting
rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001
went below the threshold of 3% and that the percentage of voting rights on
that day amounted to 2.96% (348,851 voting rights).
17.04.2014 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
Company: STRATEC Biomedical AG
End of Announcement DGAP News-Service